[go: up one dir, main page]

AR002049A1 - Una composicion farmaceutica para la administracion oral de agentes activos que tienen baja solubilidad en agua y el procedimiento para prepararla - Google Patents

Una composicion farmaceutica para la administracion oral de agentes activos que tienen baja solubilidad en agua y el procedimiento para prepararla

Info

Publication number
AR002049A1
AR002049A1 ARP960102493A AR10249396A AR002049A1 AR 002049 A1 AR002049 A1 AR 002049A1 AR P960102493 A ARP960102493 A AR P960102493A AR 10249396 A AR10249396 A AR 10249396A AR 002049 A1 AR002049 A1 AR 002049A1
Authority
AR
Argentina
Prior art keywords
water
oral administration
low solubility
prepare
procedure
Prior art date
Application number
ARP960102493A
Other languages
English (en)
Inventor
Robert Gurny
Original Assignee
Novartis Ag
Robert Gurny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Robert Gurny filed Critical Novartis Ag
Publication of AR002049A1 publication Critical patent/AR002049A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas para la adminsitración oral de agentes farmacéuticos que tienen baja solubilidad en elagua. Dichos agentes son solubilizados con un polímero adecuado para la formación denan o-partículas, especialmente de serie EUDRAGIT L y S queliberan el agente activo en regiones-objetivo específica del tracto gastrointestinal.
ARP960102493A 1995-05-08 1996-05-08 Una composicion farmaceutica para la administracion oral de agentes activos que tienen baja solubilidad en agua y el procedimiento para prepararla AR002049A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95810306 1995-05-08

Publications (1)

Publication Number Publication Date
AR002049A1 true AR002049A1 (es) 1998-01-07

Family

ID=8221740

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102493A AR002049A1 (es) 1995-05-08 1996-05-08 Una composicion farmaceutica para la administracion oral de agentes activos que tienen baja solubilidad en agua y el procedimiento para prepararla

Country Status (13)

Country Link
EP (1) EP0835103B1 (es)
JP (1) JP4128621B2 (es)
AR (1) AR002049A1 (es)
AT (1) ATE297195T1 (es)
AU (1) AU5811996A (es)
CA (1) CA2219777C (es)
DE (1) DE69634818T2 (es)
ES (1) ES2243952T3 (es)
IL (1) IL118162A (es)
PT (1) PT835103E (es)
TW (1) TW493991B (es)
WO (1) WO1996035414A1 (es)
ZA (1) ZA963584B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
FR2766368B1 (fr) * 1997-07-24 2000-03-31 Univ Claude Bernard Lyon Procede de preparation de nanocapsules de type vesiculaire, utilisables notamment comme vecteurs colloidaux de principes actifs pharmaceutiques ou autres
ATE364374T1 (de) 1997-08-11 2007-07-15 Pfizer Prod Inc Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
US6350786B1 (en) 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
ATE343562T1 (de) 2000-03-23 2006-11-15 Elan Pharm Inc Verbindungen und verfahren zur behandlung der alzheimerschen krankheit
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
EP1299352B1 (en) 2000-06-30 2005-12-28 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
US6846813B2 (en) 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
EP2184058B1 (en) 2003-09-26 2012-02-08 ALZA Corporation Drug coating providing high drug loading and methods for providing the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
EP1923051A4 (en) * 2005-09-06 2012-12-19 Astellas Pharma Inc MICROPARTICLES OF A HEAVY-DUTY SUBSTANCE WITH ENTERIAN BASE MATERIAL ADSORBED ON THE SUBSTANCE SURFACE
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
TW200946266A (en) * 2008-02-27 2009-11-16 Kuraray Co Method of manufacturing metalnanowire and dispersion medium comprising the resultant metalnanowire, and transparent conductive film
WO2010084088A2 (en) 2009-01-21 2010-07-29 Basf Se Starch nanoparticles for drug delivery systems
WO2010084060A1 (en) 2009-01-21 2010-07-29 Basf Se Starch copolymers and nanoparticles thereof for drug delivery systems
GB201006038D0 (en) 2010-04-12 2010-05-26 Unilever Plc Improvements relating to antiviral compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
US5382435A (en) * 1993-03-24 1995-01-17 Southwest Research Institute Microparticulate pharmaceutical delivery system

Also Published As

Publication number Publication date
JP4128621B2 (ja) 2008-07-30
CA2219777C (en) 2007-06-12
ZA963584B (en) 1996-11-08
ATE297195T1 (de) 2005-06-15
PT835103E (pt) 2005-10-31
DE69634818D1 (de) 2005-07-14
WO1996035414A1 (en) 1996-11-14
DE69634818T2 (de) 2006-03-23
EP0835103A1 (en) 1998-04-15
JPH11504638A (ja) 1999-04-27
TW493991B (en) 2002-07-11
CA2219777A1 (en) 1996-11-14
IL118162A0 (en) 1996-09-12
ES2243952T3 (es) 2005-12-01
IL118162A (en) 2001-10-31
AU5811996A (en) 1996-11-29
EP0835103B1 (en) 2005-06-08

Similar Documents

Publication Publication Date Title
AR002049A1 (es) Una composicion farmaceutica para la administracion oral de agentes activos que tienen baja solubilidad en agua y el procedimiento para prepararla
Hearnden et al. New developments and opportunities in oral mucosal drug delivery for local and systemic disease
ES2437846T3 (es) Formulaciones líquidas para la prevención y el tratamiento de enfermedades y trastornos de la mucosa
DK1553927T3 (da) Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
CO5650245A2 (es) Formulaciones dispersable de un agente anti-inflamatorio
CO4940409A1 (es) Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superior
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
ATE381317T1 (de) Nanopartikuläre zusammensetzungen in form festen darreichungen
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
BR9908121A (pt) Forma galênica de liberação imediata e de liberação prolongada administrável por via oral compreendendo um agente estimulador de absorção e utilização deste agente estimulador de absorção
CO5130022A1 (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial
ES2181361T3 (es) Composiciones medicinales.
JP6941839B2 (ja) 口腔止血及び創傷保護フィルム
NZ501950A (en) Medicinal compositions for application to mucosa
JPH059412B2 (es)
CY1105849T1 (el) Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος
BR112022004863A2 (pt) Composição conjugado de ligante fármaco, compostos conjugado de ligante-fármaco e conector de fármaco, e, formulação farmaceuticamente aceitável
Johnston Anatomy and physiology of the oral mucosa
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
DE602004009552D1 (de) Orales abgabesystem mit einem antibakteriellen und einem entzündungshemmenden mittel
Sposito et al. Exploiting drug delivery systems for oral route in the peptic ulcer disease treatment
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
EP0497956A1 (en) FORMULATIONS AND METHOD FOR CONTROLLED RELEASE.
SE9603480D0 (sv) Beredningsform för svårlösliga läkemedel
ES2186207T3 (es) Metodo para preparacion de formulaciones farmaceuticas.

Legal Events

Date Code Title Description
FB Suspension of granting procedure